Search Results

1 - 5 of 5
Staff
Dr. Minear is a program director in NHGRI's Division of Genomic Medicine.
… and public health.  Before joining the National Human Genome Research Institute, Dr. Minear was a Program Officer … Engineering, and Medicine (NASEM) and the American Association for the Advancement of Science (AAAS) Science & … AJ, Klintworth GK, Lass JH, Li YJ, Iyengar SK. Genome-wide association study identifies three novel loci in Fuchs …
FAQ
On October 10, 2024, NHGRI hosted a pre-application webinar for the Population Genomic Screening in Primary Care NOFOs: RFA-HG-24-021, RFA-HG-24-022, and RFA-HG-24-023. These FAQs contain questions answered during that webinar.
… this pilot study on a small number of conditions. In other studies, return of secondary fundings has been done at the … recruited by members listed in the award.   Is this nation-wide recruitment or is recruitment limited to a specific … is desirable where possible. However, the final Network-wide Community Engagement Board participants and activities …
FAQ
Questions and answers to help applicants responding to the Pre-Application Webinar for the Building Partnerships and Broadening Perspectives to Advance ELSI Research (BBAER) Program RFA-HG-24-026.
Event
On Tuesday, February 6, 2024, the National Human Genome Research Institute hosted an eConsult webinar to provide an overview of three notice of funding opportunities (RFA-HG-24-001, PAR-24-106 and PAR-24-107). Questions were answered during the webinar.
… … On Tuesday, February 6, 2024, the National Human Genome Research Institute hosted an eConsult webinar to … FAQs … On Tuesday, February 6, 2024, the National Human Genome Research Institute hosted an eConsult webinar to … … On Tuesday, February 6, 2024, the National Human Genome Research Institute hosted an eConsult webinar to …
FAQ
Questions and answers to help applicants responding to the ML/AI Tools to Advance Genomic Translational Research (MAGen) notice of funding opportunities (NOFOs): RFA-HG-24-004 and RFA-HG-24-005.
… during the course of the UG3 phase, the Consortium-wide cross validation plan will be developed anew and jointly …